Earnings Call · Q2 FY2025·2025-08-06

Q2 25EPS +4.23%·Rev n/aQ1 25EPS +3.33%·Rev n/aQ4 24EPS +9.60%·Rev n/aQ3 24EPS +12.86%·Rev n/a⚠ consensus missing

Pacira BioSciences, Inc. PCRX

Susan Mesco — Head of Investor Relations

Frank D. Lee — Chief Executive Officer

Brendan P. Teehan — Chief Commercial Officer

Shawn M. Cross — Chief Financial Officer

−0.6%1d on move date−1.4% vs SPY3d+11.7%5d+10.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PCRX calls or request research access.

More PCRX calls Browse calls Request research access